{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:31:51Z","timestamp":1793284311555,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.phrs.2025.107999","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T01:01:01Z","timestamp":1760662861000},"page":"107999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial"],"prefix":"10.1016","volume":"221","author":[{"given":"Hans-J\u00fcrgen","family":"Stellbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Postel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Seyfizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sch\u00f6ffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rico","family":"Laage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hanakam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sch\u00f6nborn-Kellenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Och","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-6265","authenticated-orcid":false,"given":"Michaela A.","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2025.107999_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/cid\/ciy562","article-title":"The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions","volume":"68","author":"Khadr","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2025.107999_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12916-019-1285-x","article-title":"Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions","volume":"17","author":"Ayoub","year":"2019","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.phrs.2025.107999_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1359105310367528","article-title":"The psychological impact of genital herpes stigma","volume":"16","author":"Merin","year":"2011","journal-title":"J. Health Psychol."},{"issue":"1","key":"10.1016\/j.phrs.2025.107999_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ijos.2016.3","article-title":"New strategies against drug resistance to herpes simplex virus","volume":"8","author":"Jiang","year":"2016","journal-title":"Int. J. Oral. Sci."},{"issue":"17","key":"10.1016\/j.phrs.2025.107999_bib5","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1073\/pnas.1220019110","article-title":"Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody","volume":"110","author":"Krawczyk","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2025.107999_bib6","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/JVI.01924-10","article-title":"Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus","volume":"85","author":"Krawczyk","year":"2011","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.phrs.2025.107999_bib7","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1111\/cts.13365","article-title":"First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers","volume":"15","author":"Blank","year":"2022","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.107999_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1008857426633","article-title":"The international development of the RGHQoL: a quality of life measure for recurrent genital herpes","volume":"7","author":"Doward","year":"1998","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.107999_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-4733.2008.00424.x","article-title":"The development of the herpes symptom checklist and the herpes outbreak impact questionnaire","volume":"12","author":"Doward","year":"2009","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.phrs.2025.107999_bib10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions","volume":"2","author":"Harding","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.phrs.2025.107999_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1143870","article-title":"Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: a retrospective study","volume":"14","author":"Alt","year":"2023","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.phrs.2025.107999_bib12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.1996.00440140169018","article-title":"A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV study group","volume":"156","author":"Spruance","year":"1996","journal-title":"Arch. Intern Med."},{"issue":"7","key":"10.1016\/j.phrs.2025.107999_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/339326","article-title":"Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment","volume":"34","author":"Leone","year":"2002","journal-title":"Clin. Infect. Dis."},{"issue":"23","key":"10.1016\/j.phrs.2025.107999_bib14","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences: a randomized clinical trial","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.phrs.2025.107999_bib15","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1093\/infdis\/jiy415","article-title":"Effects of different doses of GEN-003, a therapeutic vaccine for genital herpes simplex Virus-2, on viral shedding and lesions: results of a randomized Placebo-Controlled trial","volume":"218","author":"Van Wagoner","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.phrs.2025.107999_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11514","article-title":"Skin CD4 (+) memory t cells exhibit combined Cluster-Mediated retention and equilibration with the circulation","volume":"7","author":"Collins","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.107999_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/infdis\/jix004","article-title":"Therapeutic vaccine for genital herpes Simplex-2 infection: findings from a randoized trial","volume":"215","author":"Bernstein","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"26","key":"10.1016\/j.phrs.2025.107999_bib18","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/j.vaccine.2019.05.009","article-title":"Therapeutic HSV-2 vaccine decrerases recurrent virus shedding and recurrent genital herpes disease","volume":"37","author":"Bernstein","year":"2019","journal-title":"S. Vaccin."},{"key":"10.1016\/j.phrs.2025.107999_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fimmu.2019.00332","article-title":"Antibody-Dependent cellular phagocytosis in antiviral immune responses","volume":"10","author":"Tay","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2025.107999_bib20","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4049\/jimmunol.1800471","article-title":"A fixed spatial structure of CD8(+) t cells in tissue during chronic HSV-2 infection","volume":"201","author":"Schiffer","year":"2018","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2025.107999_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142088","article-title":"B cells, antibody-secreting cells, and virus-specific antibodies respond to herpes simplex virus 2 reactivation in skin","volume":"131","author":"Ford","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2025.107999_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867962","article-title":"HSV-2-Specific human female reproductive tract tissue resident memory t cells recognize diverse HSV antigens","volume":"13","author":"Koelle","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:08:49Z","timestamp":1773209329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S1043661825004244"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107999","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107999"}}